CERO THERAPEUTICS HOLDINGS, INC. Noncash or Part Noncash Acquisition, Fixed Assets Acquired
CERO THERAPEUTICS HOLDINGS, INC. (CERO) reported Noncash or Part Noncash Acquisition, Fixed Assets Acquired of $929.35 thousand for the 8-month period ending 2024-09-30, per its 10-Q/A filed 2024-11-20.
Financial Statements › Cash Flow › Operating Activities
us-gaap:NoncashOrPartNoncashAcquisitionFixedAssetsAcquired1 · last filed 2024-11-20
- 2024-09-30: Noncash or Part Noncash Acquisition, Fixed Assets Acquired 8 month $929.35K.
- 2024-06-30: Noncash or Part Noncash Acquisition, Fixed Assets Acquired 5 month $929.35K.
| Period end | Noncash or Part Noncash Acquisition, Fixed Assets Acquired 5 month | Noncash or Part Noncash Acquisition, Fixed Assets Acquired 8 month |
|---|---|---|
| 2024-09-30 | $929.35K 10-Q/A · filed 2024-11-20 | |
| 2024-06-30 | $929.35K 10-Q · filed 2024-08-14 |
Similar stocks
| Stock Name | Country | Market Cap | PE Ratio |
|---|---|---|---|
| CREATIVE MEDICAL TECHNOLOGY HOLDINGS, INC. (CELZ) | United States | $0.006B | |
| AIM ImmunoTech Inc. (AIM) | United States | $0.006B | |
| TScan Therapeutics, Inc. (TCRX) | United States | $0.008B | -1.23 |
| PharmaCyte Biotech, Inc. (PMCB) | United States | $0.005B | |
| WINDTREE THERAPEUTICS INC /DE/ (WINT) | United States | $0.003B | -0.32 |
| VivoSim Labs, INC. (VIVS) | United States | $0.003B | |
| Senti Biosciences Holdings, Inc. (SNTI) | United States | $0.011B | -0.70 |
| Calidi Biotherapeutics, Inc. (CLDI) | United States | $0.003B | |
| IN8BIO, INC. (INAB) | United States | $0.012B | -0.76 |
| CURIS INC (CRIS) | United States | $0.002B | -0.05 |